Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase
Keivan Zandi, Katie Musall, Adrian Oo, et al.
Microorganisms (2021) Vol. 9, Iss. 5, pp. 893-893
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 82
Perspectives on SARS-CoV-2 Main Protease Inhibitors
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 23, pp. 16922-16955
Open Access | Times Cited: 94
Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer
Liyan Yang, Zhonglei Wang
Biomedicines (2021) Vol. 9, Iss. 6, pp. 689-689
Open Access | Times Cited: 90
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
Ridhima Kaul, Pradipta Paul, Sanjay Kumar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11069-11069
Open Access | Times Cited: 85
Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays
Chunlong Ma, Haozhou Tan, Juliana Choza, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 4, pp. 1636-1651
Open Access | Times Cited: 74
Synthesis and potential applications of cyclodextrin-based metal–organic frameworks: a review
Xu Yang, Ahmed K. Rashwan, Ahmed I. Osman, et al.
Environmental Chemistry Letters (2022) Vol. 21, Iss. 1, pp. 447-477
Open Access | Times Cited: 66
Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review
Mohammad Amin Khazeei Tabari, Amin Iranpanah, Roodabeh Bahramsoltani, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3900-3900
Open Access | Times Cited: 65
A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19
Essa M. Saied, Yousra A. El‐Maradny, Alaa A. Osman, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1759-1759
Open Access | Times Cited: 58
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Latest research progress on anticancer effect of baicalin and its aglycone baicalein
Lin Wang, Ting Feng, Zhilian Su, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 8, pp. 535-557
Closed Access | Times Cited: 48
Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS‐CoV‐2 Infection and COVID‐19
Arun K. Ghosh, Jennifer L. Mishevich, Andrew D. Mesecar, et al.
ChemMedChem (2022) Vol. 17, Iss. 22
Open Access | Times Cited: 46
An overview of anti-SARS-CoV-2 and anti-inflammatory potential of baicalein and its metabolite baicalin: Insights into molecular mechanisms
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115629-115629
Closed Access | Times Cited: 40
Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine
Ling Ye, Shicheng Fan, Pengfei Zhao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 9, pp. 3598-3637
Open Access | Times Cited: 31
Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2
Mohamed S. Bekheit, Siva S. Panda, Adel S. Girgis
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115292-115292
Open Access | Times Cited: 26
The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection
Zhonglei Wang, Liyan Yang
Nutrients (2023) Vol. 15, Iss. 15, pp. 3443-3443
Open Access | Times Cited: 25
Exploring the mechanism of Radix Bupleuri in the treatment of depression combined with SARS-CoV-2 infection through bioinformatics, network pharmacology, molecular docking, and molecular dynamic simulation
Zexing Chen, Xinhua Wang, Wanyi Huang
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access | Times Cited: 1
The Chiral 5,6-Cyclohexane-fused Uracil Ring-System: a Molecular Platform with Promising Activity against SARS-CoV-2
Enrico Marcantonio, Debora Guazzetti, Crescenzo Coppa, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117302-117302
Closed Access | Times Cited: 1
An ultrasensitive high-performance baicalin sensor based on C3N4-SWCNTs/reduced graphene oxide/cyclodextrin metal-organic framework nanocomposite
Pengcheng Zhao, Linzi Huang, Hui Wang, et al.
Sensors and Actuators B Chemical (2021) Vol. 350, pp. 130853-130853
Open Access | Times Cited: 48
A Comprehensive Review of Natural Flavonoids with Anti-SARS-CoV-2 Activity
Junyu Yang, Yixuan Ma, Yan Liu, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2735-2735
Open Access | Times Cited: 22
COVID-19 Therapeutic Potential of Natural Products
Zhaoxuan Low, Rafidah Lani, Vunjia Tiong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9589-9589
Open Access | Times Cited: 19
Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD
Jieru Meng, Jiazheng Liu, Lu Fu, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 160-160
Open Access | Times Cited: 17
Inhibitory Efficacy of Main Components of Scutellaria baicalensis on the Interaction between Spike Protein of SARS-CoV-2 and Human Angiotensin-Converting Enzyme II
Cheng‐Han Lin, Ho-Ju Chang, M. C. Lin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2935-2935
Open Access | Times Cited: 7
Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources
Rajeev K. Singla, Xuefei He, Hitesh Chopra, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 34
Gossypol Broadly Inhibits Coronaviruses by Targeting RNA‐Dependent RNA Polymerases
Wenjing Wang, Wenkang Li, Zhiyuan Wen, et al.
Advanced Science (2022) Vol. 9, Iss. 35
Open Access | Times Cited: 27
The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro
Mya Myat Ngwe Tun, Kazufumi Toume, Elizabeth Luvai, et al.
Journal of Natural Medicines (2022) Vol. 76, Iss. 2, pp. 402-409
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top